Jon E. Grant to Naltrexone
This is a "connection" page, showing publications Jon E. Grant has written about Naltrexone.
Connection Strength
5.546
-
Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
Score: 0.706
-
Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1299-e1306.
Score: 0.541
-
The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
Score: 0.417
-
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
Score: 0.331
-
A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol. 2010 Nov; 20(11):823-8.
Score: 0.327
-
A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009 Apr 01; 65(7):600-6.
Score: 0.296
-
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
Score: 0.283
-
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
Score: 0.280
-
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
Score: 0.240
-
Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43(2):81-7.
Score: 0.238
-
Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol. 2005 Jan-Feb; 28(1):11-4.
Score: 0.222
-
Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004 Mar-Apr; 66(2):198-206.
Score: 0.210
-
An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
Score: 0.184
-
Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
Score: 0.184
-
A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
Score: 0.180
-
An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
Score: 0.176
-
Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
Score: 0.110
-
Compulsive buying treated with motivational interviewing and imaginal desensitization. Ann Clin Psychiatry. 2011 Aug; 23(3):226-7.
Score: 0.088
-
Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
Score: 0.079
-
Naltrexone effect on physiological and subjective response to a cold pressor task. Biol Psychol. 2008 Feb; 77(2):233-6.
Score: 0.067
-
Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
Score: 0.065
-
Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
Score: 0.060
-
Pharmacotherapy outcome in older pathological gamblers: a preliminary investigation. J Geriatr Psychiatry Neurol. 2004 Mar; 17(1):9-12.
Score: 0.052
-
Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies. Int Clin Psychopharmacol. 2002 Jul; 17(4):201-5.
Score: 0.047
-
A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001 Dec; 21(6):632-4.
Score: 0.045
-
Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry. 2001 Dec; 62(12):957-62.
Score: 0.045
-
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001 Jun 01; 49(11):914-21.
Score: 0.043
-
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009 Mar 31; 166(1):76-84.
Score: 0.018
-
Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
Score: 0.012